Exhibit 99.1
Catalyst Biosciences Sells Complement Portfolio for $60 Million
SOUTH SAN FRANCISCO, Calif. May 23, 2022 Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced that it has signed a definitive asset purchase and sale agreement with Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) under which Vertex has acquired Catalysts portfolio of protease medicines that regulate complement, including CB 2782-PEG, for $60 million in cash.
EXHIBIT 4.1
PROMISSORY NOTE
Date: May 17, 2022
FOR VALUE RECEIVED, and subject to the terms and conditions set forth herein, Avon Products, Inc., a corporation organized under the laws of the state of New York, having its registered office at 1 Avon Place, Suffern, NY 10901, USA (the “Issuer”), hereby unconditionally promises to pay to the order of Natura &Co UK Holdings Plc, a company organized and existing in accordance with the laws of United Kingdom,... (continue reading...)
More SEC Filings
View Older Stories-
Form 4 OneMain Holdings, Inc. For: May 20 Filed by: Shulman Douglas H.
-
Form D BluCarbon Investment
-
Form POS AM SVF Investment Corp. 3
-
Form 8-K AMERICAN TOWER CORP /MA/ For: May 23
-
Form 4 Alto Ingredients, Inc. For: May 20 Filed by: NATHAN GILBERT E
-
Form 6-K Zhihu Inc. For: May 23
-
Form 8-K Howmet Aerospace Inc. For: May 23
-
Form 4 Nuvectis Pharma, Inc. For: May 19 Filed by: BENTSUR RON
-
Form 4 Nuvectis Pharma, Inc. For: May 20 Filed by: Shemesh Shay
-
Form 4 Alto Ingredients, Inc. For: May 20 Filed by: Kandris Michael D
-
Form SC TO-I Symbolic Logic, Inc. Filed by: Symbolic Logic, Inc.
-
Form S-3/A Creatd, Inc.
-
Form 8-K MERITOR, INC. For: May 19
-
Form 4 electroCore, Inc. For: May 19 Filed by: Errico Thomas J.
-
Form 6-K Ascendis Pharma A/S For: May 23
-
Form 6-K CLPS Inc For: May 20
-
Form SC 13D/A Repay Holdings Corp Filed by: Morris John Andrew Sr.
-
Form D/A Pleiad Asia Master Fund
-
Form 8-K QCR HOLDINGS INC For: May 23
-
Form 8-K Predictive Oncology Inc. For: May 20
-
Form 6-K Liminal BioSciences Inc. For: May 23
-
Form 4 CVENT HOLDING CORP. For: May 19 Filed by: Iskow Julie
-
Form D Positive Sum Capital II
-
Form 8-K ASSOCIATED BANC-CORP For: May 23
-
Form 8-K EVgo Inc. For: May 18
-
Form 497K ALLSPRING FUNDS TRUST
-
Form 8-K RAPT Therapeutics, Inc. For: May 23
-
Form 8-K Triumph Bancorp, Inc. For: May 23
-
Form D TIDAL PETROLEUM INC
-
Form 4 Hall of Fame Resort & For: May 19 Filed by: Lee Benjamin J
-
Form 8-K Seagen Inc. For: May 23
-
Form 424B3 indie Semiconductor,
-
Form 8-K COLONY BANKCORP INC For: May 23
-
Form 424B3 indie Semiconductor,
-
Form 8-K INSMED Inc For: May 23
-
Form 6-K Enlivex Therapeutics For: May 23
-
Form 6-K CANADIAN NATIONAL RAILWA For: May 20
-
Form 8-K STAR EQUITY HOLDINGS, For: May 23
-
Form 8-K Tiga Acquisition Corp. For: May 20
-
Form 8-K GLAUKOS Corp For: May 23
-
Form 424B3 WOODSIDE ENERGY GROUP
-
Form 8-K OWENS & MINOR INC/VA/ For: May 23
-
Form DEF 14A Centessa Pharmaceuticals For: Jun 30
-
Form DEFA14A Jaguar Health, Inc.
-
Form DEF 14A SmartKem, Inc. For: Jun 30
-
Form 6-K CANADIAN NATIONAL RAILWA For: May 20
-
Form 8-K AGILE THERAPEUTICS INC For: May 20
-
Form 10-Q UpHealth, Inc. For: Mar 31
-
Form 8-K Invesco Real Estate Inco For: May 23
-
Form 6-K RYANAIR HOLDINGS PLC For: May 23